Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | -65,700 | 25,406 | 23,001 | 19,866 | 22,578 |
| Cost of Goods | -12,699 | 5,282 | 4,132 | 4,687 | 5,581 |
| Gross Profit | -53,001 | 20,124 | 18,869 | 15,179 | 16,997 |
| Operating Expenses | -78,501 | 60,327 | 54,180 | 45,144 | 52,185 |
| Operating Income | 24,801 | -39,921 | -35,179 | -29,278 | -34,607 |
| Interest Expense | 0 | 7,518 | 7,596 | 10,227 | 7,612 |
| Other Income | 25,349 | 19 | 123 | 122 | 132 |
| Pre-tax Income | 50,150 | -47,420 | -42,652 | -39,383 | -42,087 |
| Net Income Continuous | 50,150 | -47,420 | -42,652 | -39,383 | -42,087 |
| Net Income | $-42,960 | $-47,420 | $-42,652 | $-39,383 | $-42,087 |
| EPS Basic Total Ops | -4.96 | -5.62 | -5.41 | -5.67 | -7.50 |
| EPS Basic Continuous Ops | 6.74 | -5.62 | -5.41 | -5.67 | -7.28 |
| EPS Diluted Total Ops | -4.96 | -5.62 | -5.41 | -5.67 | -7.50 |
| EPS Diluted Continuous Ops | 6.74 | -5.62 | -5.41 | -5.67 | -7.28 |
| EBITDA(a) | $22,446 | $-38,891 | $-34,137 | $-28,259 | $-33,579 |